Anti-tumor Effects of All-trans Retinoic Acid are Enhanced by Genistein
The effects of all-trans retinoic acid (ATRA) on cancer are complex. ATRA has anti-cancer effects as it promotes cancer cell differentiation. However, ATRA also up-regulates expression of vascular endothelial growth factor (VEGF) in cancer cells, which leads to angiogenesis and can, thus, facilitate...
Gespeichert in:
Veröffentlicht in: | Cell biochemistry and biophysics 2012, Vol.62 (1), p.177-184 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 184 |
---|---|
container_issue | 1 |
container_start_page | 177 |
container_title | Cell biochemistry and biophysics |
container_volume | 62 |
creator | Zhou, Ren-Jie Yang, Xue-Qin Wang, Dong Zhou, Qian Xia, Lei Li, Meng-Xia Zeng, Lin-Li Wang, Ge Yang, Zhen-Zhou |
description | The effects of all-trans retinoic acid (ATRA) on cancer are complex. ATRA has anti-cancer effects as it promotes cancer cell differentiation. However, ATRA also up-regulates expression of vascular endothelial growth factor (VEGF) in cancer cells, which leads to angiogenesis and can, thus, facilitate cancer growth. Genistein, a crucial non-nutrient component in soybean, exhibits anti-cancer effects by inhibiting protein tyrosine kinase that is involved in up-regulation of VEGF. We hypothesized that genistein, applied simultaneously with ATRA, would counter its undesired angiogenic effects and, thus, enhance the anti-cancer effects of ATRA. The purpose of this study was to document potential synergistic effects of genistein and ATRA in A549 lung adenocarcinoma cells. We further explored the role of genistein on countering the ATRA-induced VEGF expression. We demonstrate that genistein enhances the ATRA-induced growth inhibition of A549 cells by promoting apoptosis. Further, the combined use of ATRA and genistein leads to cancer cell arrest in G0/G1 and G2/M cell cycle phases. Finally, expression of VEGF (both mRNA and protein) was diminished in A549 cells exposed to both ATRA and genistein. In conclusion, our results demonstrate that genistein effectively enhances anti-cancer effects of ATRA, particularly, by countering the ATRA-induced up-regulation of VEGF. Our study provides an experimental basis for combined use of ATRA and genistein in the treatment of lung cancer. |
doi_str_mv | 10.1007/s12013-011-9279-0 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_915628602</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2557480931</sourcerecordid><originalsourceid>FETCH-LOGICAL-c370t-f3127cc021da7dfa58ab038ca27a4f1a2aea360780af5fce3009d9f1fca680273</originalsourceid><addsrcrecordid>eNp1kMFKAzEQhoMoVqsP4EWCF0_RmaS7mxxLqVUoCKLnkGYT3bKbrcnuoW_vllYFwdMMzDf_DB8hVwh3CFDcJ-SAggEiU7xQDI7IGWbZ0HApjoceZMYUqmxEzlNaA3AOk8kpGXGUSiKoM7KYhq5iXd-0kc69d7ZLtPV0WtesiyYk-uK6KrSVpVNbldRER-fhwwTrSrra0oULVepcFS7IiTd1cpeHOiZvD_PX2SNbPi-eZtMls6KAjnmBvLAWOJamKL3JpFmBkNbwwkw8Gm6cETkUEozPvHUCQJXKo7cml8ALMSa3-9xNbD97lzrdVMm6ujbBtX3SCrOcyxz4QN78IddtH8Pw3A6CDIXaQbiHbGxTis7rTawaE7caQe8c671jPTjWO8cahp3rQ3C_alz5s_EtdQD4HkjDKLy7-Hv5_9Qv-cmFQg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>915051392</pqid></control><display><type>article</type><title>Anti-tumor Effects of All-trans Retinoic Acid are Enhanced by Genistein</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Zhou, Ren-Jie ; Yang, Xue-Qin ; Wang, Dong ; Zhou, Qian ; Xia, Lei ; Li, Meng-Xia ; Zeng, Lin-Li ; Wang, Ge ; Yang, Zhen-Zhou</creator><creatorcontrib>Zhou, Ren-Jie ; Yang, Xue-Qin ; Wang, Dong ; Zhou, Qian ; Xia, Lei ; Li, Meng-Xia ; Zeng, Lin-Li ; Wang, Ge ; Yang, Zhen-Zhou</creatorcontrib><description>The effects of all-trans retinoic acid (ATRA) on cancer are complex. ATRA has anti-cancer effects as it promotes cancer cell differentiation. However, ATRA also up-regulates expression of vascular endothelial growth factor (VEGF) in cancer cells, which leads to angiogenesis and can, thus, facilitate cancer growth. Genistein, a crucial non-nutrient component in soybean, exhibits anti-cancer effects by inhibiting protein tyrosine kinase that is involved in up-regulation of VEGF. We hypothesized that genistein, applied simultaneously with ATRA, would counter its undesired angiogenic effects and, thus, enhance the anti-cancer effects of ATRA. The purpose of this study was to document potential synergistic effects of genistein and ATRA in A549 lung adenocarcinoma cells. We further explored the role of genistein on countering the ATRA-induced VEGF expression. We demonstrate that genistein enhances the ATRA-induced growth inhibition of A549 cells by promoting apoptosis. Further, the combined use of ATRA and genistein leads to cancer cell arrest in G0/G1 and G2/M cell cycle phases. Finally, expression of VEGF (both mRNA and protein) was diminished in A549 cells exposed to both ATRA and genistein. In conclusion, our results demonstrate that genistein effectively enhances anti-cancer effects of ATRA, particularly, by countering the ATRA-induced up-regulation of VEGF. Our study provides an experimental basis for combined use of ATRA and genistein in the treatment of lung cancer.</description><identifier>ISSN: 1085-9195</identifier><identifier>EISSN: 1559-0283</identifier><identifier>DOI: 10.1007/s12013-011-9279-0</identifier><identifier>PMID: 21898109</identifier><language>eng</language><publisher>New York: Humana Press Inc</publisher><subject>Adenocarcinoma - pathology ; Antineoplastic Agents - pharmacology ; Apoptosis - drug effects ; Biochemistry ; Biological and Medical Physics ; Biomedical and Life Sciences ; Biophysics ; Biotechnology ; Cell Biology ; Cell Cycle - drug effects ; Cell differentiation ; Cell Line, Tumor ; Drug Synergism ; G1 Phase Cell Cycle Checkpoints ; G2 Phase Cell Cycle Checkpoints ; Genistein - pharmacology ; Humans ; Life Sciences ; Lung cancer ; Lung Neoplasms - pathology ; M Phase Cell Cycle Checkpoints ; Original Paper ; Pharmacology/Toxicology ; Soybeans ; Synergistic effect ; Tretinoin - pharmacology ; Up-Regulation - drug effects ; Vascular Endothelial Growth Factor A - genetics ; Vascular Endothelial Growth Factor A - metabolism</subject><ispartof>Cell biochemistry and biophysics, 2012, Vol.62 (1), p.177-184</ispartof><rights>Springer Science+Business Media, LLC 2011</rights><rights>Springer Science+Business Media, LLC 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c370t-f3127cc021da7dfa58ab038ca27a4f1a2aea360780af5fce3009d9f1fca680273</citedby><cites>FETCH-LOGICAL-c370t-f3127cc021da7dfa58ab038ca27a4f1a2aea360780af5fce3009d9f1fca680273</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12013-011-9279-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12013-011-9279-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21898109$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhou, Ren-Jie</creatorcontrib><creatorcontrib>Yang, Xue-Qin</creatorcontrib><creatorcontrib>Wang, Dong</creatorcontrib><creatorcontrib>Zhou, Qian</creatorcontrib><creatorcontrib>Xia, Lei</creatorcontrib><creatorcontrib>Li, Meng-Xia</creatorcontrib><creatorcontrib>Zeng, Lin-Li</creatorcontrib><creatorcontrib>Wang, Ge</creatorcontrib><creatorcontrib>Yang, Zhen-Zhou</creatorcontrib><title>Anti-tumor Effects of All-trans Retinoic Acid are Enhanced by Genistein</title><title>Cell biochemistry and biophysics</title><addtitle>Cell Biochem Biophys</addtitle><addtitle>Cell Biochem Biophys</addtitle><description>The effects of all-trans retinoic acid (ATRA) on cancer are complex. ATRA has anti-cancer effects as it promotes cancer cell differentiation. However, ATRA also up-regulates expression of vascular endothelial growth factor (VEGF) in cancer cells, which leads to angiogenesis and can, thus, facilitate cancer growth. Genistein, a crucial non-nutrient component in soybean, exhibits anti-cancer effects by inhibiting protein tyrosine kinase that is involved in up-regulation of VEGF. We hypothesized that genistein, applied simultaneously with ATRA, would counter its undesired angiogenic effects and, thus, enhance the anti-cancer effects of ATRA. The purpose of this study was to document potential synergistic effects of genistein and ATRA in A549 lung adenocarcinoma cells. We further explored the role of genistein on countering the ATRA-induced VEGF expression. We demonstrate that genistein enhances the ATRA-induced growth inhibition of A549 cells by promoting apoptosis. Further, the combined use of ATRA and genistein leads to cancer cell arrest in G0/G1 and G2/M cell cycle phases. Finally, expression of VEGF (both mRNA and protein) was diminished in A549 cells exposed to both ATRA and genistein. In conclusion, our results demonstrate that genistein effectively enhances anti-cancer effects of ATRA, particularly, by countering the ATRA-induced up-regulation of VEGF. Our study provides an experimental basis for combined use of ATRA and genistein in the treatment of lung cancer.</description><subject>Adenocarcinoma - pathology</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Apoptosis - drug effects</subject><subject>Biochemistry</subject><subject>Biological and Medical Physics</subject><subject>Biomedical and Life Sciences</subject><subject>Biophysics</subject><subject>Biotechnology</subject><subject>Cell Biology</subject><subject>Cell Cycle - drug effects</subject><subject>Cell differentiation</subject><subject>Cell Line, Tumor</subject><subject>Drug Synergism</subject><subject>G1 Phase Cell Cycle Checkpoints</subject><subject>G2 Phase Cell Cycle Checkpoints</subject><subject>Genistein - pharmacology</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - pathology</subject><subject>M Phase Cell Cycle Checkpoints</subject><subject>Original Paper</subject><subject>Pharmacology/Toxicology</subject><subject>Soybeans</subject><subject>Synergistic effect</subject><subject>Tretinoin - pharmacology</subject><subject>Up-Regulation - drug effects</subject><subject>Vascular Endothelial Growth Factor A - genetics</subject><subject>Vascular Endothelial Growth Factor A - metabolism</subject><issn>1085-9195</issn><issn>1559-0283</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kMFKAzEQhoMoVqsP4EWCF0_RmaS7mxxLqVUoCKLnkGYT3bKbrcnuoW_vllYFwdMMzDf_DB8hVwh3CFDcJ-SAggEiU7xQDI7IGWbZ0HApjoceZMYUqmxEzlNaA3AOk8kpGXGUSiKoM7KYhq5iXd-0kc69d7ZLtPV0WtesiyYk-uK6KrSVpVNbldRER-fhwwTrSrra0oULVepcFS7IiTd1cpeHOiZvD_PX2SNbPi-eZtMls6KAjnmBvLAWOJamKL3JpFmBkNbwwkw8Gm6cETkUEozPvHUCQJXKo7cml8ALMSa3-9xNbD97lzrdVMm6ujbBtX3SCrOcyxz4QN78IddtH8Pw3A6CDIXaQbiHbGxTis7rTawaE7caQe8c671jPTjWO8cahp3rQ3C_alz5s_EtdQD4HkjDKLy7-Hv5_9Qv-cmFQg</recordid><startdate>2012</startdate><enddate>2012</enddate><creator>Zhou, Ren-Jie</creator><creator>Yang, Xue-Qin</creator><creator>Wang, Dong</creator><creator>Zhou, Qian</creator><creator>Xia, Lei</creator><creator>Li, Meng-Xia</creator><creator>Zeng, Lin-Li</creator><creator>Wang, Ge</creator><creator>Yang, Zhen-Zhou</creator><general>Humana Press Inc</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>2012</creationdate><title>Anti-tumor Effects of All-trans Retinoic Acid are Enhanced by Genistein</title><author>Zhou, Ren-Jie ; Yang, Xue-Qin ; Wang, Dong ; Zhou, Qian ; Xia, Lei ; Li, Meng-Xia ; Zeng, Lin-Li ; Wang, Ge ; Yang, Zhen-Zhou</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c370t-f3127cc021da7dfa58ab038ca27a4f1a2aea360780af5fce3009d9f1fca680273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adenocarcinoma - pathology</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Apoptosis - drug effects</topic><topic>Biochemistry</topic><topic>Biological and Medical Physics</topic><topic>Biomedical and Life Sciences</topic><topic>Biophysics</topic><topic>Biotechnology</topic><topic>Cell Biology</topic><topic>Cell Cycle - drug effects</topic><topic>Cell differentiation</topic><topic>Cell Line, Tumor</topic><topic>Drug Synergism</topic><topic>G1 Phase Cell Cycle Checkpoints</topic><topic>G2 Phase Cell Cycle Checkpoints</topic><topic>Genistein - pharmacology</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - pathology</topic><topic>M Phase Cell Cycle Checkpoints</topic><topic>Original Paper</topic><topic>Pharmacology/Toxicology</topic><topic>Soybeans</topic><topic>Synergistic effect</topic><topic>Tretinoin - pharmacology</topic><topic>Up-Regulation - drug effects</topic><topic>Vascular Endothelial Growth Factor A - genetics</topic><topic>Vascular Endothelial Growth Factor A - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhou, Ren-Jie</creatorcontrib><creatorcontrib>Yang, Xue-Qin</creatorcontrib><creatorcontrib>Wang, Dong</creatorcontrib><creatorcontrib>Zhou, Qian</creatorcontrib><creatorcontrib>Xia, Lei</creatorcontrib><creatorcontrib>Li, Meng-Xia</creatorcontrib><creatorcontrib>Zeng, Lin-Li</creatorcontrib><creatorcontrib>Wang, Ge</creatorcontrib><creatorcontrib>Yang, Zhen-Zhou</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Cell biochemistry and biophysics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhou, Ren-Jie</au><au>Yang, Xue-Qin</au><au>Wang, Dong</au><au>Zhou, Qian</au><au>Xia, Lei</au><au>Li, Meng-Xia</au><au>Zeng, Lin-Li</au><au>Wang, Ge</au><au>Yang, Zhen-Zhou</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anti-tumor Effects of All-trans Retinoic Acid are Enhanced by Genistein</atitle><jtitle>Cell biochemistry and biophysics</jtitle><stitle>Cell Biochem Biophys</stitle><addtitle>Cell Biochem Biophys</addtitle><date>2012</date><risdate>2012</risdate><volume>62</volume><issue>1</issue><spage>177</spage><epage>184</epage><pages>177-184</pages><issn>1085-9195</issn><eissn>1559-0283</eissn><abstract>The effects of all-trans retinoic acid (ATRA) on cancer are complex. ATRA has anti-cancer effects as it promotes cancer cell differentiation. However, ATRA also up-regulates expression of vascular endothelial growth factor (VEGF) in cancer cells, which leads to angiogenesis and can, thus, facilitate cancer growth. Genistein, a crucial non-nutrient component in soybean, exhibits anti-cancer effects by inhibiting protein tyrosine kinase that is involved in up-regulation of VEGF. We hypothesized that genistein, applied simultaneously with ATRA, would counter its undesired angiogenic effects and, thus, enhance the anti-cancer effects of ATRA. The purpose of this study was to document potential synergistic effects of genistein and ATRA in A549 lung adenocarcinoma cells. We further explored the role of genistein on countering the ATRA-induced VEGF expression. We demonstrate that genistein enhances the ATRA-induced growth inhibition of A549 cells by promoting apoptosis. Further, the combined use of ATRA and genistein leads to cancer cell arrest in G0/G1 and G2/M cell cycle phases. Finally, expression of VEGF (both mRNA and protein) was diminished in A549 cells exposed to both ATRA and genistein. In conclusion, our results demonstrate that genistein effectively enhances anti-cancer effects of ATRA, particularly, by countering the ATRA-induced up-regulation of VEGF. Our study provides an experimental basis for combined use of ATRA and genistein in the treatment of lung cancer.</abstract><cop>New York</cop><pub>Humana Press Inc</pub><pmid>21898109</pmid><doi>10.1007/s12013-011-9279-0</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1085-9195 |
ispartof | Cell biochemistry and biophysics, 2012, Vol.62 (1), p.177-184 |
issn | 1085-9195 1559-0283 |
language | eng |
recordid | cdi_proquest_miscellaneous_915628602 |
source | MEDLINE; Springer Nature - Complete Springer Journals |
subjects | Adenocarcinoma - pathology Antineoplastic Agents - pharmacology Apoptosis - drug effects Biochemistry Biological and Medical Physics Biomedical and Life Sciences Biophysics Biotechnology Cell Biology Cell Cycle - drug effects Cell differentiation Cell Line, Tumor Drug Synergism G1 Phase Cell Cycle Checkpoints G2 Phase Cell Cycle Checkpoints Genistein - pharmacology Humans Life Sciences Lung cancer Lung Neoplasms - pathology M Phase Cell Cycle Checkpoints Original Paper Pharmacology/Toxicology Soybeans Synergistic effect Tretinoin - pharmacology Up-Regulation - drug effects Vascular Endothelial Growth Factor A - genetics Vascular Endothelial Growth Factor A - metabolism |
title | Anti-tumor Effects of All-trans Retinoic Acid are Enhanced by Genistein |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T14%3A53%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anti-tumor%20Effects%20of%20All-trans%20Retinoic%20Acid%20are%20Enhanced%20by%20Genistein&rft.jtitle=Cell%20biochemistry%20and%20biophysics&rft.au=Zhou,%20Ren-Jie&rft.date=2012&rft.volume=62&rft.issue=1&rft.spage=177&rft.epage=184&rft.pages=177-184&rft.issn=1085-9195&rft.eissn=1559-0283&rft_id=info:doi/10.1007/s12013-011-9279-0&rft_dat=%3Cproquest_cross%3E2557480931%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=915051392&rft_id=info:pmid/21898109&rfr_iscdi=true |